Novamind Ventures’ new CMO has led over 100 clinical trials and currently serves as a Coordinating Investigator for MAPS.

Massachusetts-based Curaleaf has become one of the largest multistate cannabis operators in the United States by adopting a broad-market approach – with scores of cultivation, processing and dispensary facilities now stretching across 23 states.

The parents of a baby girl who suffers severe seizures claim medicinal cannabis is saving her life.

One of the nation’s largest chained retailers of health supplements, The Vitamin Shoppe, is leaning into its CBD experiment with expanded plans to carry more ingestibles and topicals.

MindMed is utilizing MDMA with LSD, to endeavour to reduce side effects of LSD-assisted therapy.

Wall Street and Silicon Valley investors recently piled into a $30-million psychedelics fund-raising initiative.

Field Trip Psychedelics completes its qualifying transaction and definitive agreement with RTO partner.

A poll from the Cannabis Law Practice of law firm Brach Eichler found 66 percent of New Jersians support broad cannabis legalization in the state, with 27 percent opposed and 7 percent unsure.

Washington State marijuana regulators are looking to hire a contractor to help study marijuana odors.

Wuhan General (soon to be M2Bio Sciences) has released a corporate update on its psychedelics and cannabis operations.